Thank you for visiting the Vantage℠ Program enrollment site. We are pleased to inform you that Vantage and any applicable saving offers for VESIcare® (solifenacin succinate) tablets have been transitioned to the new Momentum program. Please click on the link below to be redirected to the Momentum enrollment site where you can begin the enrollment process and see full terms and conditions. Restrictions apply.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Enroll now